Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2025

MARKN.

The Nomination Committee proposes the election of Professor Per-Anders Abrahamsson as a new board member for AroCells Board of Directors at the 2025 Annual General Meeting.

Professor Per-Anders Abrahamsson (born in 1949) is a medical doctor and urologist with 45 years of experience as a specialist focusing on urinary tract cancer and holds a professorship at Lund University in urological oncology. He has served as clinic manager in Malmö and Lund for 20 years and as Secretary General for the world-leading scientific organization European Association of Urology from 2007 to 2015. Per-Anders Abrahamsson has previously served on the boards of both AroCell and IDL Biotech. He is currently a board member at Perituskliniken AB.

The nomination committee´s proposal for the board at the AGM is the re-election of Eva Nordström, Agneta Tufvesson Alm, Clas Runnberg, and Max Pihlqvist, and the new election of Per-Anders Abrahamsson. Fredrik Lindgren has declined re-election to the board.

The Nomination Committee proposes the re-election of Max Pihlqvist as the Chairman of the Board.
 
Other proposals from the Nomination Committee will be provided in the notice for the Annual General Meeting.

AroCells Nomination Committee consists of:
Jon Eiken (Chairman)
Jerker Swanstein
Didrik Hamilton